Tags

Type your tag names separated by a space and hit enter

[Treatment of cerebral aging disorders with Ginkgo biloba extract. A longitudinal multicenter double-blind drug vs. placebo study].

Abstract

The effectiveness of Ginkgo biloba extract in the treatment of cerebral disorders due to ageing was evaluated in a multicentric, double-blind, drug versus placebo trial involving 166 patients. In this study carried out under strict methodological conditions a specially devised geriatric clinical evaluation scale was used. The results confirmed that Ginkgo biloba extract is effective against cerebral disorders due to ageing. The difference between control and treatment groups became significant at 3 months and increased during the following months. These results were concordant with the overall clinical assessment made by the specialist in charge.

Authors

, , , , , ,

Source

Presse medicale (Paris, France : 1983) 15:31 1986 Sep 25 pg 1583-7

MeSH

Aged
Aged, 80 and over
Aging
Brain Diseases
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Longitudinal Studies
Male
Middle Aged
Placebos
Plant Extracts
Plants, Medicinal
Time Factors
Trees

Pub Type(s)

Clinical Trial
Comparative Study
Controlled Clinical Trial
English Abstract
Journal Article
Randomized Controlled Trial

Language

fre

PubMed ID

2947106

Citation

Taillandier, J, et al. "[Treatment of Cerebral Aging Disorders With Ginkgo Biloba Extract. a Longitudinal Multicenter Double-blind Drug Vs. Placebo Study]." Presse Medicale (Paris, France : 1983), vol. 15, no. 31, 1986, pp. 1583-7.
Taillandier J, Ammar A, Rabourdin JP, et al. [Treatment of cerebral aging disorders with Ginkgo biloba extract. A longitudinal multicenter double-blind drug vs. placebo study]. Presse Med. 1986;15(31):1583-7.
Taillandier, J., Ammar, A., Rabourdin, J. P., Ribeyre, J. P., Pichon, J., Niddam, S., & Pierart, H. (1986). [Treatment of cerebral aging disorders with Ginkgo biloba extract. A longitudinal multicenter double-blind drug vs. placebo study]. Presse Medicale (Paris, France : 1983), 15(31), pp. 1583-7.
Taillandier J, et al. [Treatment of Cerebral Aging Disorders With Ginkgo Biloba Extract. a Longitudinal Multicenter Double-blind Drug Vs. Placebo Study]. Presse Med. 1986 Sep 25;15(31):1583-7. PubMed PMID: 2947106.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Treatment of cerebral aging disorders with Ginkgo biloba extract. A longitudinal multicenter double-blind drug vs. placebo study]. AU - Taillandier,J, AU - Ammar,A, AU - Rabourdin,J P, AU - Ribeyre,J P, AU - Pichon,J, AU - Niddam,S, AU - Pierart,H, PY - 1986/9/25/pubmed PY - 1986/9/25/medline PY - 1986/9/25/entrez SP - 1583 EP - 7 JF - Presse medicale (Paris, France : 1983) JO - Presse Med VL - 15 IS - 31 N2 - The effectiveness of Ginkgo biloba extract in the treatment of cerebral disorders due to ageing was evaluated in a multicentric, double-blind, drug versus placebo trial involving 166 patients. In this study carried out under strict methodological conditions a specially devised geriatric clinical evaluation scale was used. The results confirmed that Ginkgo biloba extract is effective against cerebral disorders due to ageing. The difference between control and treatment groups became significant at 3 months and increased during the following months. These results were concordant with the overall clinical assessment made by the specialist in charge. SN - 0755-4982 UR - https://www.unboundmedicine.com/medline/citation/2947106/[Treatment_of_cerebral_aging_disorders_with_Ginkgo_biloba_extract__A_longitudinal_multicenter_double_blind_drug_vs__placebo_study]_ L2 - https://medlineplus.gov/seniorshealth.html DB - PRIME DP - Unbound Medicine ER -